论文部分内容阅读
目的观察丁苯酞治疗神经系统变性病的临床疗效。方法选取收治的神经系统变性病患者120例为研究对象,随机分为对照组和观察组,每组60例。对照组采用神经系统变性病的常规药物进行治疗,观察组在对照组的基础上联合丁苯酞治疗。观察2组治疗效果及ADL指数评分。结果观察组治疗总有效率为91.7%,高于对照组的81.7%(P<0.05);观察组ADL指数评分为(40.2±2.9)分,低于对照组的(48.5±3.5)分(P<0.05)。结论丁苯酞对于神经系统变性病疗效显著,不良反应少,值得临床推广应用。
Objective To observe the clinical efficacy of butylphthalide in the treatment of neurological degenerative diseases. Methods Totally 120 patients with degenerative diseases of nervous system admitted to our hospital were selected as research object and randomly divided into control group and observation group with 60 cases in each group. The control group was treated with conventional drugs of nervous system degenerative disease. The observation group was treated with butylphthalide on the basis of the control group. The therapeutic effect and ADL index were observed in two groups. Results The total effective rate of the observation group was 91.7%, which was higher than that of the control group (81.7%, P <0.05). The ADL index of the observation group was (40.2 ± 2.9) points lower than that of the control group (48.5 ± 3.5) <0.05). Conclusion Butylphthalide for the treatment of neurological degenerative disease significant effect, fewer adverse reactions, it is worth promoting the clinical application.